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O B J E C T I V E S This study sought to evaluate the association between volumetric characterization of
target lesions by multidetector computed tomography (MDCT) angiography and the risk of post-
procedural myocardial injury after elective stent implantation.
B A C KG ROUND Previous reports have shown that plaque characterization of the target lesion may
provide useful information for stratifying the risk of coronary stenting.
METHOD S A total of 189 consecutive patients were enrolled; they underwent elective stent implanta-
tion after volumetric plaque analysis with 64-slice MDCT. Each plaque component and lumen (ﬁlled with dye)
was deﬁned as follows: 1) low-attenuation plaque (LAP) (50 HU); 2) moderate-attenuation plaque (MAP) (50
to 150 HU); 3) lumen (151 to 500 HU); and 4) high-attenuation plaque (HAP) (500 HU). The volume of each
plaque component in the target lesion was calculated using Color Code Plaque. Post-procedural creatine
kinase-MB isoform and troponin-T (TnT) at 18 h after percutaneous coronary intervention were also
evaluated.
R E S U L T S The volumes of LAP (87.9  94.8 mm3 vs. 47.4  43.7 mm3, p  0.01) and MAP (111.6 
77.5 mm3 vs. 89.8  67.1 mm3, p  0.05) were larger in patients with post-procedural myocardial injury
(deﬁned as positive TnT) than in those with negative TnT. The volumes of LAP and MAP and fraction of
LAP in total plaque (LAP volume/total plaque volume) correlated with biomarkers; the MAP fraction was
inversely correlated with biomarkers. The volume of LAP was an independent predictor of positive TnT
after adjusting for patient background, conventional IVUS parameters, and procedural factors.
CONC L U S I O N S Post-procedural myocardial injury was associated with the volume and fraction of LAP as
detected by MDCT. The volume of LAP was an independent predictor of positive TnT. Plaque analysis by MDCT
would be a useful method for predicting post-procedural myocardial injury after percutaneous coronary
intervention. (J Am Coll Cardiol Img 2010;3:19–28) © 2010 by the American College of Cardiology Foundation
From the *Department of Cardiology, Chubu Rosai Hospital; †Department of Internal Medicine Aichi-Gakuin School of
Dentistry, Nagoya, Japan; and the ‡Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya,
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20ccording to current European Society of
Cardiology/American College of Cardiol-
ogy guidelines, any myocardial biomarker
elevation above the normal upper lim-
ts, in a rise-and-fall pattern, on serial blood
amples drawn after percutaneous coronary inter-
ention (PCI) allows a diagnosis of post-
rocedural myocardial injury/infarction (PMI)
See page 29
1). Previous studies have reported subclinical
reatine kinase (CK)-MB isoenzyme elevation of
% to 26% and post-procedural cardiac
roponin-T (TnT) elevation of 5% to 53% in
ost-PCI patients (2– 4). Modest elevation of
cardiac enzymes after PCI has been
shown to be associated with worse clin-
ical outcomes (5). Contrast-enhanced
magnetic resonance imaging studies
provide evidence that a post-procedural
elevation of cardiac biomarkers is asso-
ciated with microinfarction of myocar-
dial regions, originating from the target
vessel (6). Clinical, lesion, and proce-
dural characteristics related to PMI have
been indicated in various analyses (7–9).
Recently we reported a correlation be-
tween lipid-rich plaque volume, mea-
sured by radiofrequency analysis of in-
travascular ultrasound (IVUS), and the
extent of PMI (10).
In recent investigations, multidetector
computed tomography (MDCT) with ret-
rospective electrocardiographic gating has
permitted high-resolution imaging of cor-
onary arteries and plaques (11–13). Dif-
erentiation of coronary lesion morphology and
onfiguration of plaques by MDCT have been
eported previously; studies have also shown that
oft (lipid-rich), fibrous, calcified plaques show
ifferent Hounsfield units and that the distribution
f such plaque components corresponds to IVUS
ndings (14,15). However, few data exist on quan-
itative or volumetric evaluation of coronary plaque
omponents by MDCT.
It is hypothesized that 64-slice MDCT would
rovide the volumetric plaque characteristics of the
arget lesion of a patient who intends to undergo
lective stenting. This study aims to evaluate the
elationship of quantitative analysis of a target
esion with the extent of PMI, measured as cardiac
que
und
ue
n
yiomarker elevation after PCI. sE T H O D S
tudy populations. We carried out a prospectively
lanned observational study of target lesions in
atients with elective coronary stenting. Consecu-
ive patients (n  331) who planned elective coro-
ary intervention of angiographically significant
tenosis were enrolled from November 2005 to
eptember 2007; MDCT angiography was per-
ormed on 252 patients who had consented to this
tudy within 2 weeks after initial angiography. We
xcluded 8 patients who were either suspected to
ave acute coronary syndrome or had severe symp-
oms before MDCT. All participants had angina,
ocumented myocardial ischemia, or both, and
rovided informed consent to this study. The ex-
lusion criteria for this study were as follows:
atients with chronic total occlusion (n  13),
levated pre-procedural cardiac biomarkers (n 
3), angioplasty with debulking device (n  4),
ultivessel stenting in a single procedure (n  22),
nd inestimable-quality MDCT imaging (n  11).
hus, the study included 189 patients. This study
as approved by the ethics committee of Chubu
osai Hospital.
tudy protocol. The study protocol was as follows.
he computed tomographic (CT) coronary angiog-
aphy was performed using a 64-slice MDCT
ithin 2 weeks before the PCI procedure. The
osition and length of the target lesion were defined
n the basis of prior conventional angiography by
he attending physician, and an analysis of the
orresponding site of the MDCT image was per-
ormed before the PCI procedure. Coronary stent
mplantation was performed after pre-procedural
VUS recording. Finally, blood samples collected
pproximately 18 h after PCI were used to evaluate
ardiac biomarkers.
rotocol of 64-slice CT scan. The CT coronary an-
iographies were performed using a 64-slice CT
canner (Light Speed VCT, GE Healthcare,
aukesha, Wisconsin). Before CT angiography, a
est injection was performed to determine the delay
ime of the main scanning, and a monitoring scan
as acquired at the center of the ascending aorta.
o measure the time to maximum enhancement, an
nhancement curve was created during the test
njection. In the main scan, contrast material
Iopamiron 370, Nihon Schering, Osaka, Japan)
nd a saline chaser of 20 ml was injected at a rate of
.2 to 4.0 ml/s; the total volume of the contrast
aterial was 59  19 ml. The main scanningB B R E V I A T I O N S
N D A C R O N YM S
K creatine kinase
SA cross-sectional area
T computed tomography
EM external elastic
embrane
AP high-attenuation pla
VUS intravascular ultraso
AP low-attenuation plaq
APmoderate-attenuatio
laque
DCTmultidetector
omputed tomography
CI percutaneous coronar
ntervention
MI post-procedural
yocardial injury/infarctiontarted after a delay time (i.e., the time to maximum
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21nhancement for the test injection plus 3 s).
hole-heart images were acquired within a 7- to
-s breath-hold. The detector collimation was 64
.625 mm, the gantry rotation speed was 350
s/rotation, the tube voltage was 120 kV with a
urrent of 350 to 700 mA, and the table feed was 8
m/rotation.
mage reconstruction and analysis of the coronary
rtery. Axial CT images were automatically sent to
workstation (Advantage Workstation 4.2, GE
ealthcare), where they were reconstructed and
nalyzed by 2 independent human readers who were
ot involved in either the PCI procedure or the
iomarker analysis, using the CardIQ Analysis Pro
oftware package (GE Healthcare). Serial multi-
lanar reconstruction images were created. A
ylindrical-shaped, 3-dimensional region of interest
Figure 1. Representative Plaque Images
The multidetector computed tomography images of target lesions
myocardial injury (II). Color-coded maps show low-attenuation plaq
high-attenuation plaque (HAP) (red) areas. (I) Multiplanar reconstru
plaque images that represent computed tomography density (B, ax
(E) of a patient with elevated post-procedural cardiac biomarkers (t
210.8 mm3, and 0 mm3, respectively. (II) Corresponding images of a
nary intervention or elevation of post-procedural cardiac biomarker
3mm , respectively.as defined in the target lesion along the visually
stimated centerline of the target vessel in the
ultiplanar reconstruction image. The region of
nterest diameter was defined on the basis of the
uter vessel contour identified by visual estimation.
he target lesion was divided into 1 to 8 regions of
nterest as the vessel diameter varied along the
ongitudinal axis of the multiplanar reconstruction
mage. The volume of each component within the
egion of interest was measured automatically, using
olor Code Plaque analysis (GE Healthcare) (16),
ased on the stratified CT density, as described
ater.
Komatsu et al. (17) has reported plaque charac-
erization based on CT density, which shows
ood agreement between IVUS and angioscopic
ndings. On the basis of this analysis, each instance
tients with post-procedural myocardial injury (I) and without
LAP) (blue), moderate-attenuation plaque (MAP) (yellow), and
images (A, axial view; C, cross-sectional view), color-coded
iew; D, cross-sectional view), and intravascular ultrasound image
nin-T, 0.44 ng/ml). LAP, MAP, and HAP volumes were 252.8 mm3,
tient without thrombotic complication during percutaneous coro-
P, MAP, and HAP volumes were 93.8 mm3, 207.7 mm3, and 7.0in pa
ue (
ction
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22f low-attenuation plaque (LAP), moderate-
ttenuation plaque (MAP), high-attenuation
laque (HAP), and lumen (filled with contrast
racteristics
PMI ()
(n  59)
PMI ()
(n  130) p Value
68.9 9.0 70.4 10.0 0.32
36 (61.0%) 96 (73.8%) 0.11
28 (47.6%) 52 (40.0%) 0.42
40 (67.8%) 88 (67.7%) 0.99
29 (49.2%) 80 (61.5%) 0.12
16 (27.1%) 43 (33.1%) 0.51
14 (23.7%) 27 (20.8%) 0.72
25 (19.3%) 25 (19.4%) 0.99
7 (11.9%) 27 (20.1%) 0.20
42 (33.1%) 24 (42.9%) 0.26
32 (56.1%) 62 (48.4%) 0.41
l) 127.5 38.0 125.2 31.5 0.68
l) 45.1 10.8 47.4 13.8 0.29
159.4 86.6 159.6 91.1 0.98
/1.73 m2 BSA) 65.1 18.9 68.4 19.1 0.26
/l) 3.6 0.7 4.7 1.2 0.56
n (%).
ndrome; BSA  body surface area; GFR  glomerular ﬁltration rate; HDL 
DL low-density lipoprotein; MImyocardial infarction; PMI periprocedural
rocedural Characteristics
PMI ()
(n  59)
PMI ()
(n  130) p Value
27 (45.8%) 52 (40.0%) 0.79
20 (33.9%) 52 (40.0%)
11 (18.6%) 25 (19.2%)
1 (1.7%) 1 (0.8%)
16 (27.1%) 33 (25.4%) 0.94
22 (37.3%) 32 (24.6%) 0.11
25 (42.4%) 46 (35.4%) 0.45
(mm) 2.68 0.47 2.69 0.58 0.90
18.5 7.4 12.9 7.7 0.01
meter (mm) 1.02 0.60 1.03 0.44 0.93
12.5 5.16 10.9 3.30 0.05
a (mm2) 2.50 1.16 2.61 1.05 0.62
%) 110.3 21.8 96.1 18.8 0.09
ics
1.49 0.57 1.42 0.64 0.48
ressure (atm) 15.4 5.24 15.9 4.61 0.54
s) 125.8 81.3 114.9 68.9 0.37
9 (15.3%) 25 (19.2%) 0.55
n (%).
embrane cross-sectional area; IVUS  intravascular ultrasound; LAD  left
ary artery; LCX  left circumﬂex coronary artery; LMT  left main trunk; PMI 
injury; QCA  quantitative coronary angiography; RCA  right coronary artery;vrt Association/American College of Cardiology classiﬁcation type B2 or type C.edium) was defined as having a CT density of
50 HU, 50 to 150 HU, 500 HU, and 151 to
00 HU, respectively. The fraction of each plaque
omponent, defined as the volume of each compo-
ent divided by the total plaque volume, was also
stimated (Fig. 1).
CI procedure. All patients enrolled in this study
nderwent elective coronary stent implantation,
ith or without balloon pre-dilation. All patients
eceived antiplatelet agents for at least 24 h before
he procedure. Furthermore, 10,000 IU of heparin
as administered before the procedure, and an
dditional bolus of 1,000 IU was given every hour if
he procedure lasted for more than 1 h. The
lycoprotein IIb/IIIa receptor inhibitor has not
een approved in Japan, and none of the patients
eceived it. All procedures were performed using 6-
o 8-F guiding catheters, with either a radial or a
emoral approach. A successful PCI, which was
efined as50% residual stenosis and final Throm-
olysis In Myocardial Infarction (TIMI) flow grade
, was realized in each of the enrolled patients. We
tarted the administration of clopidogrel (loading
ose 75 to 300 mg and daily maintenance dose 75
g) in each patient to prevent stent thrombosis
fter stent implantation.
ngiography and IVUS. Angiography and IVUS re-
ults were evaluated by an independent investigator
ho was not involved in the procedures but was
ware of the final outcomes. A computerized quan-
itative analysis system (QCA-CMS system, ver-
ion 3.32, MEDIS, Leiden, the Netherlands) was
sed with a guiding catheter for calibration. Angio-
raphic measurements included reference diameter,
inimum lumen diameter, percentage of diameter
tenosis, and lesion length.
The IVUS studies were performed after intra-
oronary injections of 1,000 g isosorbide dinitrate
ith a mechanical sector scanner (Atlantis SR Pro,
oston Scientific Corporation, Natick, Massachu-
etts) and a motorized transducer pullback system
0.5 mm/s). Image slices of minimum lumen, prox-
mal reference, and distal reference sites were ana-
yzed according to previously described methods
18). The cross-sectional area (CSA) of the external
lastic membrane (EEM), lumen CSA, plaque plus
edia CSA (EEM CSA minus lumen CSA), and
laque burden (plaque plus media CSA/EEM
SA) of these slices were measured. The remodel-
ng index was defined as follows: target lesion EEM
SA divided by the average of the proximal and
istal reference EEM CSA. To compare plaqueTable 1. Baseline Cha
Age (yrs)
Male
Diabetes
Hypertension
Dyslipidemia
Obesity
Smoking
History of ACS
Previous MI
Beta-blockers
Statins
LDL cholesterol (mg/d
HDL cholesterol (mg/d
Triglyceride (mg/dl)
Estimated GFR (ml/min
C-reactive protein (mg
Values are mean  SD or
ACS  acute coronary sy
high-density lipoprotein; LTable 2. Lesion and P
LAD
RCA
LCX
LMT
Bifurcational lesion
Calciﬁed lesion
Type B2/C lesion
QCA measurements
Reference diameter
Lesion length (mm)
Minimum lumen dia
IVUS measurements
Target EEM (mm2)
Minimum lumen are
Remodelling index (
Procedural characterist
Number of stents
Maximum inﬂation p
Total inﬂation time (
Direct stenting
Values are mean  SD or
EEM  external elastic m
anterior descending coron
periprocedural myocardialolume measured by MDCT and IVUS, the total
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23laque volume by IVUS was calculated in 60
andomly selected lesions. The total plaque volume
as calculated as the sum of plaque plus media in
ach CSA, at 1-mm axial intervals, from the IVUS
mages of the target lesion.
valuation of cardiac biomarkers. Blood was sampled
efore the procedure and 18 h after the procedure.
erum TnT was measured with an enzyme immu-
oassay kit (Roche Diagnostics, Tokyo, Japan), the
etection limit of which was 0.03 ng/ml; linearity
as achieved between 0.1 and 2 ng/ml. A TnT level
f 0.03 ng/ml was considered as 0 ng/ml (nega-
ive), and 0.03 to 0.1 ng/ml was considered as 0.1
g/ml; a TnT level of 2 ng/ml was considered as
ng/ml. The PMI was defined as a post-procedural
nT level of 0.1 ng/ml on the basis of the
anufacturer’s statement regarding the clinical cut-
ff value for TnT. The CK-MB activity was mea-
ured using an immunoinhibition assay kit (Sysmex,
obe, Japan).
tatistics. All data are expressed as mean  SD
alues. A comparison of continuous variables was
chieved with an unpaired Student t test or a
ann-Whitney U test, and categorical variables
ere derived by a chi-square analysis or Fisher exact
robability test. We used Bland-Altman and linear
egression analyses for comparison of plaque vol-
me measured by MDCT and IVUS. Linear re-
ression analysis was performed to assess the asso-
iation of quantitative plaque characterization by
DCT with an increase in cardiac biomarkers. To
dentify predictors of PMI, we performed univariate
nd multivariate analyses using the logistic regres-
ion method. Variables with a significance level of
0.2 in the univariate analysis were considered
andidate variables for inclusion in the multivariable
nalysis. A receiver-operator characteristic curve
nalysis was performed to examine the possibility of
sing LAP volume to diagnose patients with post-
rocedural TnT elevation (0.1, 0.2, and 0.3
g/ml, respectively). Differences were considered
ignificant at p  0.05.
E S U L T S
aseline patient, lesion, and procedural charac-
eristics. Post-procedural TnT elevation of 0.10
g/ml occurred in 59 (31.2%) patients. The clinical
haracteristics of the entire study population are
isted in Table 1. No significant differences were
ound between patients with and without PMI.
esion and procedural characteristics are listed in
able 2. In terms of angiographic measurements, (esion length was significantly greater in patients
ith positive TnT. No difference was found in
erms of IVUS measurements or procedural
haracteristics.
olumetric plaque measurements using MDCT. Forty
andomly selected lesions were measured by 2
bservers. Their measurements showed good corre-
ation vis-à-vis total plaque volume (r2  0.76, p 
.01), LAP volume (r2  0.78, p  0.01), MAP
olume (r2  0.76, p  0.01), and HAP volume
r2  0.74, p  0.01). To validate plaque volume
easurements by MDCT, we compared plaque
olume measurements by MDCT and IVUS on
0 randomly selected lesions (Fig. 2). Plaque
olumes measured by MDCT and IVUS showed
significant correlation (r2  0.63, p  0.01). In
land-Altman plots, mean differences in volume
ere 3.77  53.5 mm3. The upper and lower
imits for plaque volume agreement were between
101.1 mm3 (95% confidence interval [CI]:
124.8 to 108.6) and 108.6 mm3 (95% CI:
4.9 to 132.4).
Figure 3 shows measurements of each plaque com-
onent obtained by MDCT. Total plaque volumes
223.8  165.5 mm3 vs. 150.9  113.3 mm3, p 
.01), LAP volumes (87.9  94.8 mm3 vs. 47.4 
3.7 mm3, p  0.01), and MAP volumes (111.6 
7.5 mm3 vs. 89.8  67.1 mm3, p  0.05) were
ignificantly larger in patients with PMI; the fractions
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To validate plaque volume measurements by MDCT, a comparison
volume between MDCT and IVUS was carried out on 60 randomly s
lesions. The correlation coefﬁcient for plaque volumes measured by
and IVUS was r2  0.63 (p  0.01). In Bland-Altman plots, the mean
ences in volume were 3.77  53.5 mm3. The limits of agreement fo
volume were between 101.1 mm3 (95% CI: 124.8 to 108.6) an
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24f LAP (32.9  15.0% vs. 29.0  10.5%, p  0.05)
nd HAP (12.9  16.5% vs. 8.4  13.4%, p  0.05)
n plaque were higher in patients with PMI. In
ontrast, the fraction of MAP in plaque was lower in
atients with PMI (54.2 13.9% vs. 62.6 14.0%).
ost-procedural increase in cardiac biomarkers.
imple and multiple regression analyses with post-
rocedural TnT (log transformed) were performed;
he results are listed in Table 3. The LAP (Fig. 4A),
AP, and HAP volumes significantly correlated
ith post-procedural TnT (log transformed) and
K-MB values. However, although the fraction of
AP in plaque correlated positively with TnT and
K-MB (Fig. 4B), that of MAP correlated in-
he Volume and Fraction of Each Plaque Component (LAP,
HAP) of Target Lesion in Patients With or Without
l Injury
e (223.8  165.5 mm3 vs. 150.9  113.3 mm3, p  0.01), LAP
.8 mm3 vs. 47.4  43.7 mm3, p  0.01), and MAP (111.6  77.5
.8  67.1 mm3, p  0.05) volumes were signiﬁcantly larger in
th PMI (A); the fractions of LAP (32.9% vs. 29.0%, p  0.01) and
vs. 8.4%, p  0.05) in plaque were higher in patients with PMI
ction of MAP was lower in patients with PMI (54.2% vs. 62.6%,
HAP  high-attenuation plaque; LAP  low-attenuation plaque;
derate-attenuation plaque; PMI  post-procedural myocardial
ction.ersely with each of the 2 biomarkers. bMultivariable linear regression analysis showed
hat LAP volume was independently associated
ith post-procedural TnT (Table 4). We also
ound that the fraction of LAP in plaque was
ignificantly associated with post-procedural TnT,
ven after adjusting for significant confounding
actors (p  0.2 in a simple regression analysis).
redictor of PMI. In this study population, PMI was
bserved in 59 patients (31.2%). Multivariate logis-
ical regression analysis showed that larger volumes
f LAP were independently associated with PMI,
ven after adjusting for significant confounding
actors (Table 5). Although a higher LAP fraction
as independently associated with PMI, a lower
AP fraction was associated with PMI. Neither
he volume of HAP nor its fraction in plaque was
ssociated with PMI. A receiver-operator charac-
eristic analysis of LAP volume to identify post-
rocedural TnT elevation (0.1 ng/ml, 0.2 ng/ml,
nd 0.3 ng/ml) is shown in Table 6.
I S C U S S I O N
olumetric plaque characterization and PMI. This
tudy showed that LAP and MAP volumes were
arger in patients who had incurred myocardial
njury after stent implantation. The MAP volume
orrelated positively and MAP fraction in plaque
orrelated inversely with biomarkers. On the other
and, both the volume of LAP and its fraction
orrelated positively with biomarkers. These find-
ngs suggest that MAP volume does not essentially
ontribute to a post-procedural elevation of cardiac
iomarkers. Therefore, in multivariate analysis, a
arger LAP volume, higher LAP fraction, and
ower MAP fraction were each identified as inde-
endent predictors of post-procedural cardiac bio-
arker elevation.
Distal embolism after stent expansion may play
n important role in the development of a PMI.
ecent studies on distal protection devices confirm
obilization of plaque material after coronary
tenting in patients with stable or unstable angina
19). When the stent was expanded in the lesion,
he stent strut grated up the plaque and broke up
nd loosened the microembolic debris, releasing it
nto the bloodstream (thus demonstrating the so-
alled cheese-grater effect) (20). Therefore, plaque
hat contains larger lipid-rich or soft components
ay be prone to being broken down into larger
umbers of atherosclerotic particles after stent ex-
ansion. These hypotheses are strongly supportedFigure 3. T
MAP, and
Myocardia
Total plaqu
(87.9  94
mm3 vs. 89
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25olume after stenting is significantly related to a
ass of post-procedural myonecrosis being detected
y enhanced magnetic resonance imaging (21), and
aseline plaque characteristics evaluated by ultra-
ound radiofrequency data (i.e., virtual histology)
re associated with procedure-related distal embo-
ism (22,23).
uantitative analysis of coronary plaques using MDCT.
n addition to evaluating luminal narrowing, non-
alcified coronary atherosclerotic plaque can fre-
uently be visualized by MDCT. Investigations
nto the quantitative measurements of plaque areas,
emodeling index, and plaque volume measurement
y MDCT have been reported (14,24,25). On the
ssumption that lipid-rich plaque has lower CT
ensity than fibrous plaque, investigators have at-
empted to use measurements with CT attenuation
alues to differentiate plaque types. A plaque profile
s determined by MDCT may represent different
tages of atherosclerosis as assessed by histopatho-
ogical findings (26), gray-scale IVUS (15,17), and
irtual histology analysis (27).
There seems to be a large overlap of plaque
haracteristics between patients with and without
MI. Previous reports comparing IVUS and
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Figure 4. Scatter Plots of Post-Procedural TnT and CK-MB Versu
Scatter plots of post-procedural troponin-T (A) and CK-MB (B) versu
cantly correlated with post-procedural TnT (log-transformed) and C
itively with TnT (log-transformed) and CK-MB, that of MAP was foun
creatine kinase; TnT  troponin-T; other abbreviations as in Figure 3.DCT show a wide overlap of density values
easured within hyperechoic and hypoechoic
laques (28). This finding results from the natural
ourse of atherosclerotic plaque evolution and tech-
ical factors that affect density measurements, such
s slice width and contrast medium concentration
25,28–30). These findings raise concerns about the
ccuracy of distinguishing lipid-rich plaque from
brous plaque and detecting vulnerable plaque
olely on the basis of measurements of CT density.
owever, recent studies have shown that LAP
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. However, although the fraction of LAP in plaque correlated pos-
be inversely correlated with each of the 2 biomarkers. CK 
Table 3. Linear Regression Analysis Between Each Plaque Comp
Post-Procedural TnT and CK-MB
Plaque Troponin-T (Log Transformed)
Plaque volume (mm3)
LAP r 0.552, p 0.001
MAP r 0.346, p 0.001
HAP r 0.156, p 0.033
Plaque volume fraction (%)
LAP r 0.265, p 0.001
MAP r0.344, p 0.001
HAP r 0.098, p 0.178
CK  creatine kinase; HAP  high-attenuation plaque; LAP  low-atten
moderate-attenuation plaque; TnT  troponin-T.tten
-atte
s V
s vo
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d toonent and
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26etected by MDCT is associated with acute coro-
ary syndrome (31,32) and a no-reflow phenome-
on during elective PCI (33). These reports, as well
s the present study, suggest that plaque with a
arger LAP volume may be a high-risk finding, even
f it does not closely correspond to a lipid-rich or
ecrotic histological pattern.
Comparative results of plaque volume measured
y MDCT and IVUS in our study (r2  0.63, p 
.001) are similar to those reported by Leber et al.
24) (r2  0.69, p  0.001). Because the coronary
rtery is surrounded by tissue with a density that
ppears in scans and the resolution of MDCT is
elatively low compared with that of IVUS, it is
ifficult to define its outer edges accurately. How-
ver, in the current study, the interobserver agree-
ent of MDCT measurements was relatively good.
Thrombus and noncalcified plaque had similar
T densities, and it was difficult to differentiate
etween these tissue components by MDCT (31).
n this study population, the noncalcified plaque
Table 4. Simple- and Multiple-Regression Analysis With Peripro
Variable
Simple Reg
Coefﬁcient (95% CI)
LAP volume* 0.007 (0.005 to 0.009)
Fraction of LAP (%)* 0.019 (0.008 to 0.031)
Age 0.011 (0.005 to 0.026)
HAP volume 0.005 (0.001 to 0.009)
Lesion length (mm, QCA) 0.052 (0.030 to 0.074)
EEM (mm2, IVUS) 0.046 (0.003 to 0.094)
Total inﬂation time (s) 0.001 (0.000 to 0.004)
Remodelling index (IVUS) 0.008 (0.002 to 0.018)
Number of stents implanted 0.168 (0.070 to 0.406)
History of acute coronary syndrome 0.224 (0.123 to 0.572)
MAP volume 0.004 (0.002 to 0.006)
*Volume and fraction of low-attenuation plaque were included separately in th
CI  conﬁdence interval; MDCT  multidetector computed tomography; othe
istic Regression Models for Prediction of PMI
Exp () (95% CI) p Value
3, MDCT) 3.07 (1.48–6.35) 0.01
3, MDCT) 1.79 (0.92–3.49) 0.09
3, MDCT) 1.92 (0.63–5.95) 0.25
1.06 (1.01–1.10) 0.01
0.95 (0.91–0.98) 0.01
1.02 (0.98–1.05) 0.33
for history of ACS, lesion length (QCA), EEM (IVUS), remodelling index (IVUS),
tal ballooning (inﬂation) time. *The fraction of each plaque component was
multivariate model.
drome; Exp exponential function; QCA quantitative coronary angiography;tables 2 to 4.etected by MDCT may contain a certain amount
f thrombus, thus it may be difficult to differentiate
hrombus from noncalcified plaque, although no
mergency PCI for acute coronary syndrome was
ncluded in this study.
tudy limitations. We stratified coronary plaque ac-
ording to a previous report by Komatsu et al. (17),
lthough the MDCT device, contrast medium, and
can protocols used by them were different from
hose used in this study. In our investigation, plaque
tratification was not validated by comparison with
ther modalities.
We obtained post-procedural blood samples only
nce, at 18 h after PCI. It may not be practicable
or investigators in daily practice to collect multiple
lood samples from a patient and at the same time
o avoid apparent complications or confounding
actors. However, 100% of peak TnT elevations and
2% of the peak CK-MB values were observed
ithin 12 to 20 h (mean 17.9  0.46 h) after the
rocedure in patients who had undergone elective
CI and had no pre-procedural elevations in car-
iac biomarkers (34). Therefore, we evaluated only
ardiac biomarkers obtained from single blood sam-
les obtained 18 h after PCI.
A relatively low incidence of statin pre-treatment
as observed in this study, although the beneficial
ffect of statin therapy on patients who have under-
one PCI has been established (7,35). A relatively
mall sample size, single-center analysis, and arbi-
rary definition of PMI were also limitations of the
urrent study. To avoid such arbitrariness, we per-
ormed multivariable analyses using TnT as a con-
ral Troponin-T (Log Transformed)
ion
Multiple Regression
(r  0.684, p < 0.001)
p Value Coefﬁcient (95% CI) p Value
0.001 0.010 (0.006 to 0.014) 0.001
0.001 0.027 (0.010 to 0.046) 0.003
0.171 0.030 (0.007 to 0.052) 0.011
0.022 0.005 (0.108 to 0.077) 0.088
0.001 0.017 (0.008 to 0.042) 0.182
0.064 0.039 (0.022 to 0.101) 0.209
0.068 0.002 (0.002 to0.005) 0.326
0.108 0.004 (0.006 to 0.014) 0.445
0.165 0.154 (0.263 to 0.570) 0.464
0.194 0.141 (0.288 to 0.569) 0.514
0.001 0.001 (0.008 to0.006) 0.528
ultivariate model.
breviations as in Tables 2 and 3.cedu
ress
e mTable 5. Multiple Log
Variables
LAP volume (/100 mm
MAP volume (/100 mm
HAP volume (/100 mm
Fraction of LAP (%)*
Fraction of MAP (%)*
Fraction of HAP (%)*
This model was adjusted
number of stents, and to
included separately in the
ACS acute coronary syninuous variable.
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27O N C L U S I O N S
e have shown a significant correlation between LAP
olume within target lesions, as measured by MDCT,
nd post-procedural elevation of cardiac biomarker levels.
he LAP volume was found to be an independent
redictor of PMI after elective stenting.
Although successful dilatation of coronary stenosis
ight improve myocardial perfusion and can be ex-
ected to reduce cardiovascular events, other benefits
f PCI to stable patients with optimal medical therapy
re controversial (36). The procedure-related myocar-
ial infarction is a major roadblock to improving
linical outcomes in patients who undergo PCI.
laque evaluation by MDCT may provide useful
nformation to identify high-risk patients who are
Table 6. Receiver-Operator Characteristic Analysis for the Volum
Cutoff Level of TnT
(ng/ml)
Best Discriminating Value
of LAP Volume (mm3)
A
(95%
TnT 0.1 52.5 0.62 (0.
TnT 0.2 52.5 0.73 (0.
TnT 0.3 54.0 0.83 (0.
AUC  area under the curve; CI  conﬁdence interval; LAP  low-attenuation6. Riccardi MJ, Uw E, Davidson CJ,
et al. Visualization of discrete micro- Eur Heart J 2008;29edical treatment or bypass surgery. Evaluation of
oronary plaque by MDCT involves significantly
reater exposure to radiation as well as to the
ontrast medium. Therefore, further evaluation of
he clinical benefits of this technique is required.
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f LAP to Identify Post-Procedural TnT Elevation
I)
p Value
(Area  0.5)
Sensitivity (%)
(95% CI)
Speciﬁcity (%)
(95% CI)
.69) 0.01 55.9 (42.4–68.8) 74.6 (66.2–81.8)
.79) 0.01 73.3 (54.1–87.7) 72.3 (64.7–79.1)
.88) 0.01 92.3 (63.9–98.7) 71.6 (64.3–78.1)
ue; TnT  troponin-T.xpected to have a better outcome with aggressive london.electricity@gmail.com.1
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